Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Biotech
J&J, Google venture arms line up to back EpiBiologics' series B
Protein degradation biotech EpiBiologics brought in $107 million in a series B round headed up by J&J's and Google's respective venture arms.
James Waldron
Jan 8, 2026 9:05am
J&J junks $1.2B eczema therapy while Genmab drops cancer drug
Jan 2, 2026 9:05am
Following Medtronic, J&J nets liquid embolic nod in brain bleeds
Dec 19, 2025 10:51am
Link emerges to connect CAR-T therapy across solid, liquid tumors
Dec 15, 2025 1:18pm
Fierce Pharma
ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma
Dec 9, 2025 7:30am
FDA panel votes against J&J shunt implant for heart failure
Dec 5, 2025 4:31pm
